TOG Review (RCOG Journal)
MRCOG Part 2
Core Surgical Skills
Laparoscopic myomectomy
Key Statistics
- ~1600/yr — Myomectomies performed in UK
- 70–80% — Lifetime fibroid incidence (European/African origin)
- 1 in 500–100 — Age-related leiomyosarcoma risk (<30 to 75–79yr)
Don't-miss facts
-
No preoperative test definitively excludes leiomyosarcoma – must be stated explicitly during consent for LM/morcellation
-
Age-related leiomyosarcoma risk (Brohl): 1 in 405 at 40–44yr vs 1 in 216 at 50–54yr; use power morcellation with extreme caution if LM offered >45yr
-
FDA occult leiomyosarcoma prevalence estimate 1 in 350 (2014) was criticised – recalculated 1 in 1550 (Parker) to 1 in 8300 (Pritts)
-
Overall LM complications ~11% (major 2%); conversion to open 1%; emergency hysterectomy 0.0–0.3%
-
Parasitic myomata/DPL after morcellation: incidence 0.1–1%; uncontained morcellation obscures leiomyosarcoma diagnosis in 20% of cases
-
Vasopressin doses as low as 0.2 units/ml may cause severe cardiopulmonary complications – liaise with anaesthetist
-
Misoprostol 400 micrograms vaginally preoperatively + intraoperative vasopressin = moderate-quality evidence for reduced blood loss (Cochrane 2014)
-
In-bag morcellation is still experimental – no proven prognostic benefit for unsuspected malignancy
Evidence/consent essentials
Gold standard: LM for ≤3 symptomatic fibroids, fertility desired
Consent musts: parasitic myomata/DPL, occult malignancy upstaging, no test excludes leiomyosarcoma
Abbreviation Key
- LM — laparoscopic myomectomy
- RCOG — Royal College of Obstetricians and Gynaecologists
- HMB — heavy menstrual bleeding
- GnRH-a — gonadotrophin-releasing hormone agonist
- MRI — magnetic resonance imaging
- DPL — disseminated peritoneal leiomyomatosis
- UAE — uterine artery embolisation
- FDA — US Food and Drug Administration
- MRgFUS — magnetic resonance-guided focused ultrasound
- AAGL — American Association of Gynecologic Laparoscopists
- RCT — randomised controlled trial
- BSGE — British Society for Gynaecological Endoscopy
- NICE — National Institute for Health and Care Excellence
Source: Bryant-Smith A, Holland T. Laparoscopic myomectomy: a review of alternatives, techniques and controversies. The Obstetrician & Gynaecologist 2018;20:261–268. doi:10.1111/tog.12520
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).